Replies to post #14916 on GTC Biotherapeutics (fka GTCB)

[DewDiligence]

>I couldn't find a timeline for CD137 in the RMF... what are your thoughts?<

The CD137 program has been in preclinical development for 4.5 years. It may represent interesting science, but I no longer take the program seriously from a business standpoint.